« FDA approves Xgeva to help prevent cancer-related bone injury Xgeva, | Main | FDA clears Cymbalta to treat chronic musculoskeletal pain The U.S. »

FDA approves new treatment option for late-stage breast cancer Halaven,


FDA approves new treatment option for late-stage breast cancer
Halaven, metastatic breast cancer
 

©2006 FDA-News.com. All rights reserved.